Procainamide Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01035 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Tourette syndrome | KG + DL |
| 2 | hyperthyroidism | KG + DL |
| 3 | Prinzmetal angina | KG + DL |
| 4 | methemoglobinemia, alpha type | KG + DL |
| 5 | methemoglobinemia | KG + DL |
| 6 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 7 | trichotillomania | KG + DL |
| 8 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 9 | methemoglobin reductase deficiency | KG + DL |
| 10 | rheumatoid arthritis | KG + DL |
| 11 | Graves disease | KG + DL |
| 12 | gout | KG + DL |
| 13 | hyperthyroxinemia | KG + DL |
| 14 | neonatal thyrotoxicosis | KG + DL |
| 15 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 16 | brachydactyly-syndactyly syndrome | KG + DL |
| 17 | malignant hypertensive renal disease | KG + DL |
| 18 | malignant renovascular hypertension | KG + DL |
| 19 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 20 | hypertensive disorder | KG + DL |
| 21 | manic bipolar affective disorder | KG + DL |
| 22 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 23 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 24 | conjunctivitis | KG + DL |
| 25 | methemoglobinemia due to deficiency of methemoglobin reductase | KG + DL |
| 26 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 27 | diabetic nephropathy | KG + DL |
| 28 | Braddock syndrome | KG + DL |
| 29 | fibromyalgia | KG + DL |
| 30 | chronic pulmonary heart disease | KG + DL |
| 31 | idiopathic granulomatous myositis | KG + DL |
| 32 | myositis fibrosa | KG + DL |
| 33 | tendinitis | KG + DL |
| 34 | Hashimoto thyroiditis | KG + DL |
| 35 | open-angle glaucoma | KG + DL |
| 36 | primary hereditary glaucoma | KG + DL |
| 37 | nephrogenic diabetes insipidus | KG + DL |
| 38 | autoimmune thyroid disease | KG + DL |
| 39 | thyroid gland disease | KG + DL |
| 40 | hyperplasia | KG + DL |
| 41 | bronchitis | KG + DL |
| 42 | toxic diffuse goiter | KG + DL |
| 43 | exostosis | KG + DL |
| 44 | diabetes insipidus, nephrogenic, X-linked | KG + DL |
| 45 | inclusion body myositis | KG + DL |
| 46 | conjunctivitis (disease) | KG + DL |
| 47 | thyrotoxicosis | KG + DL |
| 48 | selective pituitary resistance to thyroid hormone | KG + DL |
| 49 | subacute thyroiditis | KG + DL |
| 50 | subacute lymphocytic thyroiditis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.